Jeff Yass’s Outlook Therapeutics OTLK Stock Holding History

Jeff Yass's OTLK Position: Q2 2026 in Review

Jeff Yass increased its Outlook Therapeutics (OTLK) stake by 622% in Q2 2026, buying an estimated $517K and bringing the position to 968,190 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #7096.

Jeff Yass first reported a position in OTLK in Q1 2018 and has held it in 20 quarters since. 70 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

• Jeff Yass held 968,190 shares of Outlook Therapeutics worth $1.54M as of Q2 2026.
• Jeff Yass bought 834,106 Outlook Therapeutics shares in Q2 2026, an estimated $517K.
• Outlook Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7096 holding.
• Jeff Yass first reported a position in Outlook Therapeutics in Q1 2018 and has held it in 20 quarters since.
• 70 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.